Purple Biotech Ltd (PPBT) News
Follow Purple Biotech Ltd (PPBT) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
U.S. factory orders rise 0.9% in July, topping estimates
U.S. factory orders rose 0.9% month-over-month in July, compared with estimates for a 0.7% gain.
MACRO | Sep 02, 2026, 04:01 PM UTC
L
Purple Biotech says new U.S. patent allowance strengthens CAPTN-3 platform protection
Purple Biotech (PPBT) announced a U.S. patent allowance that strengthens protection for its CAPTN-3 modular platform for next-generation multispecific antibodies.
GEOPOLITICS | Sep 02, 2026, 11:37 AM UTC
L
PPBT - New U.S. Patent Allowance Strengthens Protection for CAPTN-3 Modular Platform for Next-Generation Multispecific Antibodies - Click Fo
PPBT - New U.S. Patent Allowance Strengthens Protection for CAPTN-3 Modular Platform for Next-Generation Multispecific Antibodies
EQUITY | Sep 02, 2026, 11:30 AM UTC